CD34 and acute myeloid leukemia: As anticipated, the most significant difference was found with NPM1mut/FLT3-ITD CD34+CD38− leukemic cells (MFI p = 0.0151) (Figure 5E), further confirming very high CD123 expression in this AML subset.